Routine usage of sentinel node biopsy in melanoma management must cease
A. Dixon
Department of Research, Australasian College of Cutaneous Oncology, Docklands, Victoria, Australia
Search for more papers by this authorH. Steinman
DermOne Dermatology Centre, Department of Dermatology, Irving, TX, U.S.A.
Search for more papers by this authorA. Nirenberg
Department of Pathology, Australasian College of Cutaneous Oncology, Docklands, Victoria, Australia
Search for more papers by this authorJ. Dixon
Baker IDI Heart and Diabetes Institute, Department of Research, Melbourne, Victoria, Australia
Search for more papers by this authorA. Dixon
Department of Research, Australasian College of Cutaneous Oncology, Docklands, Victoria, Australia
Search for more papers by this authorH. Steinman
DermOne Dermatology Centre, Department of Dermatology, Irving, TX, U.S.A.
Search for more papers by this authorA. Nirenberg
Department of Pathology, Australasian College of Cutaneous Oncology, Docklands, Victoria, Australia
Search for more papers by this authorJ. Dixon
Baker IDI Heart and Diabetes Institute, Department of Research, Melbourne, Victoria, Australia
Search for more papers by this author
References
- 1Morton DL, Thompson JF, Cochran AJ et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 2006; 355: 1307–17.
- 2Morton DL, Thompson JF, Cochran AJ et al. Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med 2014; 370: 599–609.
- 3Morton DL, Cochran AJ, Thompson JF et al. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial. Ann Surg 2005; 242: 302–11.
- 4Wilke LG, McCall LM, Posther KE et al. Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial. Ann Surg Oncol 2006; 13: 491–500.
- 5Roaten JB, Pearlman N, Gonzalez R et al. Identifying risk factors for complications following sentinel lymph node biopsy for melanoma. Arch Surg 2005; 140: 85–9.
- 6Nikolakis G, Zampeli VA, Brunner M, Zouboulis CC. [Pigment accumulation in a sentinel lymph node patient with malignant melanoma. Lymph node tattoo]. Hautarzt 2015; 66: 137–9 (in German).
- 7Kretschmer L, Thoms KM, Peeters S et al. Postoperative morbidity of lymph node excision for cutaneous melanoma – sentinel lymphonodectomy versus complete regional lymph node dissection. Melanoma Res 2008; 18: 16–21.
- 8Rietman JS, Dijkstra PU, Geertzen JH et al. Short-term morbidity of the upper limb after sentinel lymph node biopsy or axillary lymph node dissection for stage I or II breast carcinoma. Cancer 2003; 98: 690–6.
- 9Menzies M, Atkinson V, Brown M et al. Sentinel node biopsy for melanoma: the medical oncology perspective. Aust Fam Physician 2015; 44: 873–6.
- 10Retsas S, Henry K, Mohammed MQ, MacRae K. Prognostic factors of cutaneous melanoma and a new staging system proposed by the American Joint Committee on Cancer (AJCC): validation in a cohort of 1284 patients. Eur J Cancer 2002; 38: 511–16.
- 11Saw R, Allan C, Barbour A et al. Sentinel node biopsy in patients with intermediate and thick melanomas – a balanced view. Aust Fam Physician 2015; 44: 873–6.
- 12Spillane A, Read R, Thompson J. Reply. Aust Fam Physician 2015; 44: 873–6.
